Introduction
Glycogen synthase kinase-3b (GSK-3b) is a serine/ threonine kinase which controls numerous cellular functions by phosphorylating many substrates, including protein synthesis, gene expression, subcellular localization of proteins and protein degradation (Plyte et al., 1992; Cohen and Frame, 2001; Doble and Woodgett, 2003) . Although the mechanisms by which GSK-3b regulates the functions of many substrates specifically and selectively are not fully understood, one possibility is that GSK-3b determines the substrate specificity by binding to it directly or indirectly. So far we have identified several GSK-3b-binding proteins including Axin, Axil, AKAP220 and h-prune Yamamoto et al., 1998; Tanji et al., 2002; Kobayashi et al., 2006) . The complexes including GSK-3b and the binding protein have distinct localization and specific functions. They regulate b-catenin stability, cyclic-AMP-dependent protein kinase (PKA) signaling and cell migration by cooperating with GSK-3b.
Evidence has accumulated that GSK-3b regulates microtubule stability and determines cell polarity. Two microtubule-associating proteins (MAPs), Tau and MAP1B, are phosphorylated by GSK-3b, and the phosphorylation of MAPs regulates their binding to microtubules, thereby modulating microtubule stability. GSK-3b, which is inactivated on the plus ends of microtubules, mediates Par6-protein kinase Cz (PKCz)-dependent promotion of polarization and cell protrusion through microtubules (Etienne-Manneville and Hall, 2003) . The binding of adenomatous polyposis coli gene product (APC) to microtubules increases the stability of microtubules, and the interaction of APC and microtubules is decreased by the phosphorylation of APC by GSK-3b (Zumbrunn et al., 2001) .
We have recently found that GSK-3b binds and phosphorylates Bicaudal-D (BICD) (Fumoto et al., 2006) . BICD is a human homologue of Drosophila Bicaudal-D (Suter et al., 1989) and there are two homologues in mammals, BICD1 and BICD2 (Hoogenraad et al., 2001) . BICD proteins consist of three coiled-coil domains and are involved in dynein-mediated minus end-directed transport from the Golgi apparatus to the endoplasmic reticulum (Matanis et al., 2002; Hoogenraad et al., 2003) . In addition to these roles of BICD, we showed that GSK-3b functions in transporting centrosomal proteins to the centrosome by stabilizing the BICD and dynein complex, resulting in the regulation of a focused microtubule organization (Fumoto et al., 2006) . Therefore, GSK-3b could be involved in the regulation of the centrosomal functions. It was also reported that GSK-3b is inactivated by protein kinase B (PKB) at the spindle poles in the mitotic phase (Wakefield et al., 2003) .
However, the roles of GSK-3 in the spindle poles are not known.
Aurora-A is a mitotic kinase that plays critical roles in the centrosome cycle, spindle assembly and chromosome segregation (Meraldi et al., 2004; Marumoto et al., 2005) . The protein level of Aurora-A is temporally regulated by ubiquitin-dependent proteolysis at the end of mitosis, before cells progress into the G 1 phase of the next cell cycle. Aurora-A is ubiquitinated by the Cdh1-activated anaphase-promoting complex/cyclosome (APC/C), an E3 ubiquitin ligase (Zachariae and Nasmyth, 1999) . Furthermore, the localization and activation of Aurora-A at the spindles during mitosis is regulated by TPX2 Kufer et al., 2002) . The action of TPX2 on Aurora-A is mediated by small GTPase Ran that facilitates microtubule polymerization and bipolar spindle assembly (Tsai et al., 2003) . Regulation of the stability and activity of Aurora-A is important for mitotic progression, because reduction of Aurora-A in the cells causes delay in mitotic entry (Hirota et al., 2003) and overexpression of Aurora-A leads to abnormal centrosome amplification, chromosomal instability and transformation (Bischoff et al., 1998) . Aurora-A is located in the chromosome 20q13 region, a region that is frequently amplified in breast cancers and in diverse cancer cell lines. Overexpression of Aurora-A in primary human tumors indeed correlates with poor prognosis and invasiveness (Marumoto et al., 2005) .
In addition to APC/C and TPX2, Aurora-A-interacting protein (AIP) was originally identified as a protein that binds and downregulates Aurora-A through two distinct ubiquitin-dependent and ubiquitin-independent pathways (Kiat et al., 2002; Lim and Gopalan, 2007) . However, the regulation and physiological significance of AIP-dependent degradation of Aurora-A are not clear. Here we showed that GSK-3b interacts with AIP and that this kinase is involved in the regulation of AIP-dependent degradation of Aurora-A in early mitotic phase.
Results

GSK-3b binds and phosphorylates AIP
To clarify the roles of GSK-3b in mitotic phase, we screened GSK-3b-binding protein(s) by yeast two hybrid screening and identified the AIP clone encoding amino acids 73-199. Among several candidate proteins, we focused on AIP, because AIP is known to regulate stability of Aurora-A in mitotic phase (Kiat et al., 2002) . To verify this interaction in intact cells, we overexpressed green fluorescent protein (GFP)-tagged AIP (GFP-AIP) in HEK293T cells. When the cell lysates were immunoprecipitated with anti-GFP antibody, endogenous GSK-3b was found in the GFP-AIP immune complex (Figure 1a) . Reciprocally, GFP-AIP was coprecipitated with endogenous GSK-3b by anti-GSK-3b antibody (Figure 1b) . Furthermore, endogenous GSK-3b was coimmunoprecipitated with endogenous AIP in HeLa S3 cells by anti-AIP antibody ( Figure 1c ). These results indicate that AIP is a novel binding partner of GSK-3b.
We coexpressed GFP-AIP with various hemagglutinin (HA)-tagged kinase-inactive mutants of GSK-3b or a constitutively active mutant in HEK293T cells and found that GFP-AIP is coprecipitated with these mutants as well as wild-type GSK-3b (Figure 1d) . Furthermore, SB216763, a specific inhibitor of GSK-3, did not affect the formation of a complex between GFP-AIP and endogenous GSK-3b (data not shown), indicating that their interaction does not require the kinase activity of GSK-3b.
To examine whether AIP is a substrate of GSK-3b, we carried out an in vitro phosphorylation assay using recombinant six histidine-tagged GSK-3b (His 6 -GSK-3b) and maltose-binding protein (MBP)-fused AIP (MBP-AIP). MBP-AIP was phosphorylated by GSK-3b in vitro (Figure 1e ). GSK-3 is known to phosphorylate consensus sequences such as S/TXXXS/T (S, serine; T, threonine; X, any amino acid) and S/TP (P, proline) (Plyte et al., 1992) . AIP contains two possible phosphorylation sites 72 SPLES and 191 TP. The GFP-AIP mutants, in which these serine and threonine residues were substituted by alanine, were expressed in HEK293T cells and the immunoprecipitates with anti-GFP antibody were used as substrates. Among the AIP mutants, only GFP-AIP T191A showed severe impairment of phosphorylation by GSK-3b (Figure 1f ), suggesting that Thr191 is a possible site of phosphorylation by GSK-3b. The reason why GFP-AIP was phosphorylated without addition of GSK-3b might be that AIP is phosphorylated by endogenous GSK-3b or other coprecipitated kinases. GFP-AIP T191A and GFP-AIP S72/76A formed a complex with GSK-3b in HEK293T cells to the similar extent to GFP-AIP (wild type; Supplementary Figure 1a) . In addition, MBP-AIP T191A bound His 6 -GSK-3b in vitro with similar efficiency to MBP-AIP (wild type) (Supplementary Figure 1b) . Therefore, the failure of the phosphorylation of AIP T191A by GSK-3b was not due to the fact that AIP T191A lost the ability to bind GSK-3b. To examine whether AIP is phosphorylated by GSK3b in intact cells, HeLa S3 cells were metabolically labeled with 32 Pi. We found that AIP is a phosphoprotein, but treatment of the cells with SB216763 did not decrease the phosphorylation of AIP in intact cells (data not shown). Therefore, GSK-3 may not affect the net phosphorylation state of AIP and other protein kinases are thought to be involved in the phosphorylation of AIP. Consistent with this, casein kinase I, PKA and cyclin-dependent kinase 5 also phosphorylated AIP in vitro (data not shown). Therefore, we examined whether the phosphorylation of AIP by GSK-3b affects the functions of AIP in the following experiments.
AIP is colocalized with Aurora-A to spindle pole We examined the roles of AIP in mitotic phase. When HeLa S3 cells were treated with thymidine and nocodazole and then the cell cycle arrest was released, the endogenous protein level of AIP changed during the cell cycle, with increased expression during mitosis, although the increase was delayed relative to those of Aurora-A and cyclin B (Figure 2a) . As the cells exited mitotic phase (2-4 h after cell cycle arrest was released), when the decreases of Aurora-A and cyclin B were observed (Kimura et al., 1997; Bischoff et al., 1998) , the protein level of AIP was also decreased.
Indirect immunofluorescence microscopy showed that AIP was weakly stained and diffusely distributed in interphase cells (data not shown). A significant signal Figure 2c ). Therefore, the staining with anti-AIP antibody indicated the localization of endogenous AIP. Endogenous AIP and Aurora-A were colocalized to the spindle poles (Figure 2d ). To confirm the colocalization of AIP and Aurora-A, GFP-AIP was expressed in HEK293T cells. GFP-AIP (Figure 2d ), but not GFP (data not shown), was indeed detected at the spindle poles with Aurora-A.
It has been reported that GSK-3b is located to the spindle poles in mitotic cells (Wakefield et al., 2003) . GSK-3b and Aurora-A were indeed colocalized to the spindle poles (Figure 2d ). Taking these results together with the biochemical interaction between AIP and GSK-3b, it seems that AIP, Aurora-A and GSK-3b are colocalized to the spindle poles. These results suggest that AIP is involved in progression of the cell cycle in cooperation with Aurora-A and GSK-3b.
Depletion of AIP results in cell arrest in early mitotic phase To clarify the roles of AIP in cell cycle control, siRNA duplexes for AIP were transfected into asynchronously growing HeLa S3 cells. Knockdown of AIP caused an increase in the population of mitotic cells (Figure 3a) . We quantified the frequency of each part of the mitotic phase in these mitotic cells. More than 96% of AIP knockdown cells were in prophase to metaphase, whereas 72% of control cells were in these mitotic phases (Figure 3b) , suggesting that knockdown of AIP results in arrest in early mitotic phase. To further characterize the phenotype of AIP knockdown cells, we followed individual mitotic cells using time-lapse microscopy in HeLa cells stably expressing histone H2B-GFP (HeLa/H2B-GFP cells) (Hirota et al., 2003) . A delay of exit from metaphase was observed upon knockdown of AIP (Figure 3c ).
We also found that the depletion of AIP causes a high incidence of cell arrest in early mitotic phase of Vero cells (Figure 3d ). This arrest phenotype induced by knockdown of AIP was rescued by stably expressing AIP that is RNA interference (RNAi)-resistant in Vero cells (Figure 3d ). Therefore, AIP is indeed required for cell cycle progression. Furthermore, the distance between the two spindle poles was markedly shortened and mitotic spindles were bundled (Figure 3e ). This phenotype induced by knockdown of AIP was rescued by knockdown of Aurora-A (Figure 3e) . Therefore, AIP knockdown-mediated phenotypes might be due to the stabilization of Aurora-A.
AIP is required for the downregulation of Aurora-A during early mitotic phase To clarify the mechanism of mitotic progression mediated by AIP, AIP knockdown HeLa S3 cells were synchronized by thymidine and nocodazole (Figures 4a  and b) . Knockdown of AIP increased the protein level of Aurora-A when nocodazole was released (time 0), but the stabilized Aurora-A was decreased at 2 h after nocodazole release as well as in control cells (Figures 4a  and b) . These data suggest that depletion of AIP increases the level of Aurora-A in interphase and early mitotic phase but not in late mitotic phase. TPX2, an activator of Aurora-A, was also increased in AIP knock- 
t a p h a s e m e t a p h a s e a n a p h a s e t e lo p h a s e
Regulation of mitotic progression by AIP and GSK-3 K Fumoto et al antibody (Figures 4a and b ) and the enzymatic activity was measured using myelin basic protein as a substrate (Figure 4c ). Therefore, AIP may be required for Aurora-A activity through finely regulating the Aurora-A protein level at early mitotic phase.
Phosphorylation of AIP by GSK-3b decreases its ability to downregulate Aurora-A To explore a potential mechanistic link among GSK-3b, AIP and Aurora-A, we applied SB216763, a GSK-3 inhibitor, to HeLa S3 cells synchronized with nocodazole. SB216763 treatment reduced the level of Aurora-A in control mitotic cells (Figure 5a ). Although knockdown of AIP increased Aurora-A, the effects of SB216763 on the protein level of Aurora-A was decreased in AIP knockdown cells (Figure 5a ). Therefore, the kinase activity of GSK-3b may be involved in the AIP-dependent degradation of Aurora-A. To further clarify the mechanism, we expressed AIP or AIP T191A with Myc-Aurora-A in HEK293T cells. AIP reduced the level of Myc-Aurora-A, and AIP T191A further decreased the level of Myc-Aurora-A (Figure 5b ). The protein level of Aurora-A was partially recovered by lactacystin, a proteasome inhibitor (Figure 5b ). Taken together with the recent observation that AIP promotes Aurora-A degradation through an alternative ubiquitin-independent pathway (Lim and Gopalan, 2007) , these results suggest that Aurora-A may be degraded by AIP in proteasome-dependent and -independent manners.
Although GFP-AIP formed a complex with Myc-Aurora-A in HEK293T cells expressing both proteins, it was hard to detect the formation of a complex between GFP-AIP T191A and Myc-Aurora-A (data not shown). The inability to detect complex formation might have been due to robust degradation of Myc-Aurora-A. Therefore, we immunoprecipitated the transiently expressed GFP-AIP or GFP-AIP T191A from HEK293T cell lysates followed by the addition of GST-His 6 -tagged Aurora-A (Figure 5c ). The amount of GST-His 6 -Aurora-A coprecipitated with wild-type GFP-AIP was lower compared to the amounts coprecipitated with GFP-AIP T191A . Recombinant MBP-AIP and MBP-AIP T191A purified from Escherichia. coli directly bound GST-His 6 -Aurora-A in vitro with the similar efficiency (data not shown), indicating that the increased binding activity of AIP T191A immunoprecipitated from HEK293T cells to Aurora-A was not simply due to the structural change caused by the mutation of Thr191 to Ala. These results suggest that inhibition of the phosphorylation of AIP by GSK-3b enhances the binding of AIP to Aurora-A, thereby inducing the downregulation of Aurora-A. Thus, GSK-3b and AIP may cooperatively regulate cell cycle progression by fine-tuning the stability of Aurora-A.
Discussion
Aurora-A is a mitotic kinase that plays critical roles in the centrosome cycle and spindle assembly (Meraldi et al., 2004; Marumoto et al., 2005) . APC/C regulates Aurora-A stability as cells progress from metaphase. However, how the stability of Aurora-A in early mitotic phase is regulated has not yet been clarified. In the present study, we identified AIP as an early mitotic regulator that downregulates Aurora-A under the regulation by GSK-3b. This conclusion is based on the findings that AIP binds GSK-3b at endogenous level and is phosphorylated by GSK-3b, that AIP is colocalized with Aurora-A on the spindle poles in early mitotic phase, that AIP knockdown induces prometaphase arrest and increases the protein level and activity of Aurora-A, and that the AIP mutant, in which the possible phosphorylation site of GSK-3b is mutated, binds and downregulates Aurora-A more efficiently than wild type.
Recent studies have shown that GSK-3 kinase activity is required for proper chromosome alignment Regulation of mitotic progression by AIP and GSK-3 K Fumoto et al reported that Aurora-A knockdown also induces the chromosome misalignment , it is reasonable to assume that one of the reasons for chromosome misalignment induced by the GSK-3 inhibitor is due to the Aurora-A downregulation. Furthermore, we showed that the downregulation of Aurora-A by the inhibition of GSK-3b is suppressed in the AIP knockdown cells. Taken together, these findings strongly suggest that GSK-3 regulates the level of Aurora-A through AIP. In addition, the inactivated form of GSK-3b is present at the spindle poles at metaphase presumably through PKB (Wakefield et al., 2003) . Therefore, it is possible that the level of phosphorylation of AIP by GSK-3b is decreased when AIP is accumulated to the spindle poles in early mitotic phase. The unphosphorylated form of AIP may bind Aurora-A efficiently and regulate the protein level and activity of Aurora-A to an appropriate level, which in turn may play a role in early mitotic phase. Thus, the temporal and spatial regulation of the activity of GSK-3b toward AIP would be important to ensure proper mitotic progression. We also found that TPX2 is increased by the AIP knockdown. Although the mechanism by which the protein level of TPX2 was increased in AIP knockdown cells is not known, abnormal activation of Aurora-A by TPX2 in early mitotic phase may also cause the cells to arrest at metaphase. Therefore, the phenotypes observed in AIP knockdown cells may have been due to secondary consequences of the elevated level and activity of Aurora-A in early mitotic phase. AIP might be required to fine-tune the level of Aurora-A by downregulating it during mitosis. However, although the expression level of AIP was higher in late mitotic phase than early mitotic phase, AIP was not accumulated at the spindle poles in late mitotic phase. Therefore, it is also conceivable that AIP has another function to regulate mitotic progress independently of Aurora-A.
We found the length between spindle poles was shortened in the AIP knockdown cells. This phenotype was suppressed by the simultaneous knockdown of Aurora-A. These results suggest that AIP regulates the spindle organization through the regulation of the level of Aurora-A. Although we also examined the localization of Aurora-A and TPX2 in the AIP knockdown cells, we could not find any defect in their localization on the mitotic spindle and spindle poles (data not shown), suggesting that AIP regulates the protein level and activity of Aurora-A rather than interference of the localization of Aurora-A and TPX2 on the mitotic spindle apparatus. However, since fluorescence recovery after photobleaching study showed that GFP-Aurora-A rapidly exchanges in and out of the centrosome and mitotic spindle (Stenoien et al., 2003) , we cannot exclude and Myc-Aurora-A had been incubated with or without 15 mM of lactacystin for 6 h, the cell lysates were probed with anti-Myc, anti-GFP and anti-clathrin antibodies. Clathrin was used as a loading control. (c) Lysates of HEK293T cells expressing GFP, GFP-AIP or GFP-AIP T191A were immunoprecipitated with anti-GFP antibody. The immunoprecipitates were incubated with 1.5 mM GST-His 6 -Aurora-A in 100 ml of 50 mM Tris/HCl (pH 7.5), 1 mM dithiothreitol and 10 mM MgCl 2 for 1 h at 4 1C to examine the binding activities of AIP and AIP
T191A
to Aurora-A. The samples were precipitated by centrifugation and probed with anti-His 6 (right top panel) and anti-GFP (right middle panel) antibodies. The expression levels of GFP, GFP-AIP and GFP-AIP T191A in samples were proved with anti-GFP as shown in the 'Expression' panel. The amount of GST-His 6 -Aurora-A precipitated with GFP-AIP or GFP-AIP T191A was quantified in the left panel. *Po0.001. the possibility that the regulation of Aurora-A by AIP affects the dynamic movement of the Aurora-A around mitotic spindles.
It has been reported that the phosphorylation of Xenopus Aurora-A at Ser290/291 by GSK-3 inhibits the kinase activity of Aurora-A (Sarkissian et al., 2004) . Although this finding appears to be opposite to our observation that GSK-3b strengthens the functions of Aurora-A indirectly, these serine residues are not conserved in human and mouse Aurora-A. Direct effect of GSK-3b on Aurora-A remains to be clarified.
Materials and methods
Materials and chemicals
Anti-Thr288-phosphorylated Aurora-A antibody was kindly provided by T Urano (Shimane University, Izumo, Japan). HeLa cells expressing histone H2B-GFP (HeLa/H2B-GFP), and polyclonal anti-Aurora-A antibody were generated as described (Hirota et al., 2003) . A synthesized peptide of the middle portion (residues 103-120) or C-terminal fragment (residues 183-199) of AIP was used to generate anti-AIP antibody in a rabbit. The anti-Myc antibody was prepared from 9E10 cells. Anti-GFP, anti-cyclin B, rabbit anti-Aurora-A and anti-TPX2 antibodies were purchased from Molecular Probes (Eugene, OR, USA), Cell Signaling (Beverly, MA, USA), Transgenic (Kumamoto, Japan), Life Span Biosciences (Seattle, WA, USA), respectively. Anti-GSK-3b, mouse monoclonal anti-Aurora-A and anti-Hsp90 antibodies were from BD Transduction Laboratory (San Diego, CA, USA). Anti-b-actin, anti-b-tubulin and mouse monoclonal and rabbit polyclonal anti-g-tubulin antibodies were from Sigma (St Louis, MO, USA). SB216763 was from TOCRIS.
Plasmid construction pCGN/GSK-3b (WT), pCGN/GSK-3bK85M, pCGN/GSK3b K85R , pCGN/GSK-3b 216F , pCGN/GSK-3b S9A and pRSETC/ GSK-3b were constructed as previously described Hino et al., 2003) . Standard recombinant DNA techniques were used to construct the following plasmids: pEF-BOS-Myc/Aurora-A, pET42a( þ )/Aurora-A, pEGFPC1/ AIP, pEGFPC1/AIP S72/76A , pEGFPC1/AIP T150A , pEGFPC1/ AIP T191A and pMalC2/AIP.
Synchronization of cells
Cells were blocked with 2.5 mM thymidine for 22 h followed by 6 h of release before 10 ng/ml nocodazole (Sigma) was added, and the culture was continued for an additional 6 h. Mitotic cells were collected by mitotic shake-off, washed twice with phosphate buffered saline, and incubated in fresh pre-warmed medium. Samples were taken at various times after release. For microscopy analyses, cells were blocked with thymidine for 22 h followed by 12 h of release before fixation.
RNA interference
SiRNA was transfected into HeLa S3 cells with Oligofectamine (Invitrogen, Carlsbad, CA, USA) or into Vero cells with Lipofectamine 2000 (Invitrogen) for 48 h before synchronization. Since the siRNA duplexes were transfected in 90% of HeLa S3 cells using this method, the effects of untransfected cells are ignored. The siRNA duplexes used were 5 0 -GAGACGCAAGCAGAUCAAG-3 0 for AIP, 5 0 -AUGCCC UGUCUUACUGUCA-3 0 for Aurora-A and 5 0 -CAGUCGC GUUUGCGACUGG-3 0 for the control (scramble). For rescue experiments, an RNAi-resistant construct of AIP (pCAG/AIP) was generated with PCR-based techniques by introducing silent substitutions in the target site of the siRNA for AIP (the primer sequence: 5 0 -GCGGCGGAAACAA AUUAAA-3 0 ). Vero cell lines stably expressing this construct were then generated.
Live-cell imaging HeLa/H2B-GFP cells were observed with an Olympus IX81ZDC microscope, and MetaMorph software was used to collect and process data. Images were captured at 50-ms exposure times with 5-min intervals for 16 h.
Phosphorylation assay by GSK-3b in vitro The phosphorylation of AIP by GSK-3b was carried out as described . Recombinant MBP-AIP (1 mg of protein) or GFP-AIP immunoprecipitated from HEK293T cells were incubated with His 6 -GSK-3b (0.1 mg of protein) in 30 ml of reaction mixture (50 mM Tris-HCl pH7.5, 10 mM MgCl 2 , 1mM dithiothreitol, 50 mM [g- 
Statistical analyses
The experiments were performed at least three times and the results were expressed as means ± s.d. Differences between the data were tested for statistical significance by the t-test. P-values less than 0.05 were considered statistically significant.
Others
Yeast two-hybrid screening was carried out as previously described . Immunoprecipitation, western blotting and immunofluorescence studies were performed as described (Yamamoto et al., 2003; Kobayashi et al., 2006) , and the results shown are representative of three independent experiments. The data of western blotting were quantified with Image J software.
